Previous Close | 2.3300 |
Open | 2.4300 |
Bid | 2.3100 x 0 |
Ask | 2.3600 x 0 |
Day's Range | 2.2700 - 2.4900 |
52 Week Range | 1.5600 - 10.8700 |
Volume | |
Avg. Volume | 2,446,311 |
Market Cap | 469.8M |
Beta (5Y Monthly) | 3.04 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.2000 |
Earnings Date | Feb 09, 2022 - Feb 14, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.43 |
Canadian cannabis stocks soared Monday morning, with Tilray Brands (NASDAQ: TLRY), Canopy Growth (NASDAQ: CGC), and Aurora Cannabis (NASDAQ: ACB) spiking between 11% and 17% in earlier trading. As of 1:50 p.m. ET, Tilray remained up 6.3%, while Canopy Growth and Aurora were 16.5% and 7.1% higher, respectively. The jumps come as there continues to be hope for some level of marijuana legalization legislation making it through the U.S. Senate this year.
Trulieve CEO Kim Rivers sits down with Yahoo Finance Live to discuss the cannabis company's latest earnings report and outlook ahead of cannabis regulation bills.
After tumbling on Friday following a lousy earnings report from Canopy Growth (NASDAQ: CGC), shares of fellow Canadian marijuana stocks Tilray (NASDAQ: TLRY) and Aurora Cannabis (NASDAQ: ACB) -- and Canopy Growth, too -- are rebounding sharply today. As of 11:30 a.m. ET, Tilray shares are gaining 10.2%, Aurora is up 12.3%, and Canopy Growth is doing best of all, jumping 16.4%. The opposite is more accurate, with investment bank Piper Sandler coming out with a lower price target on Canopy -- $2.50 per share, down from $3 previously -- and an underweight rating to boot.